Methods and compositions for producing vitamin K dependent proteins
View Patent ↗The present invention relates to methods and compositions for improving the productivity of recombinant vitamin K dependent protein expression in host cells.
1. An isolated host cell comprising a recombinant nucleic acid coding for a functional vitamin K epoxide reductase (VKOR), wherein the recombinant nucleic acid coding for the VKOR comprises a nucleotide sequence selected from the group consisting of:
1) a nucleotide sequence that encodes an amino acid sequence having at least 80% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR;
2) a nucleotide sequence that that encodes a human VKOR;
3) a nucleotide sequence that encodes a mouse VKOR;
4) a nucleotide sequence that encodes a rat VKOR;
5) a nucleotide sequence that encodes a zebrafish VKOR;
6) a nucleotide sequence that encodes a Xenopus VKOR; and
7) a nucleotide sequence that encodes an Anopheles VKOR,
and a recombinant nucleic acid coding for a vitamin K dependent protein, wherein both the recombinant VKOR and the recombinant Vitamin K dependent protein are expressed in said host cell.
2. The host cell of claim 1 , wherein either the nucleic acid coding for recombinant VKOR or the nucleic acid coding for the recombinant Vitamin K dependent protein or both are expressed via an expression mode selected from the group consisting of one or more of the following: induced, transient, and permanent expression.
3. The host cell of claim 1 , wherein the host cell is a mammalian cell.
4. The host cell of claim 3 , wherein the mammalian cell is a cell derived from a mammalian cell line selected from the group consisting of one or more of the following: CHO cells and HEK293 cells.
5. The host cell of claim 1 , wherein the recombinant vitamin K dependent protein comprises a coagulation factor.
6. The host cell of claim 1 , wherein the coagulation factor is selected from the group consisting of one or more of the following: factor II, factor VII, factor VIIA, factor IX, factor X, prothrombin, Protein C, activated Protein C and Protein S.
7. The host cell of claim 6 , wherein the coagulation factor comprises human factor IX.
8. The host cell of claim 6 , wherein the coagulation factor comprises human factor VII.
9. A cell culture system comprising isolated cells that contain a recombinant nucleic acid coding for a functional vitamin K epoxide reductase (VKOR), wherein the recombinant nucleic acid coding for the VKOR comprises a nucleotide sequence selected from the group consisting of:
1) a nucleotide sequence that encodes an amino acid sequence having at least 80% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR;
2) a nucleotide sequence that that encodes a human VKOR;
3) a nucleotide sequence that encodes a mouse VKOR;
4) a nucleotide sequence that encodes a rat VKOR;
5) a nucleotide sequence that encodes a zebrafish VKOR;
6) a nucleotide sequence that encodes a Xenopus VKOR; and
7) a nucleotide sequence that encodes an Anopheles VKOR, and a recombinant nucleic acid coding for a vitamin K dependent protein, wherein both the recombinant VKOR and the recombinant Vitamin K dependent protein are expressed in said cells.
10. The cell culture system of claim 9 , wherein the cultured cells are mammalian cells.
11. The cell culture system of claim 10 , wherein the mammalian cells are selected from the group consisting of one or more of the following: CHO cells and HEK293 cells.
12. The cell culture system of claim 9 , wherein the recombinant Vitamin K dependent protein is a coagulation factor.
13. The cell culture system of claim 12 , wherein the coagulation factor is selected from the group consisting of one or more of the following: factor II, factor VII, factor VIIa, factor IX, factor X, prothrombin, Protein C, activated Protein C and Protein S.
14. The cell culture system of claim 13 , wherein the coagulation factor comprises human factor IX.
15. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:
(a) providing the isolated host cell of claim 1 ; and
(b) expressing the recombinant nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.
16. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:
(a) providing the isolated host cell of claim 1 , having a recombinant nucleic acid coding for a vitamin K dependent protein integrated into its genome; and
(b) expressing the nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.
17. The method of claim 16 , wherein the recombinant nucleic acid coding for a vitamin K dependent protein is stably expressed.
18. A method of producing a vitamin K dependent protein in a host cell, comprising the steps of:
(a) providing the isolated host cell of claim 1 , having a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) integrated into its genome; and
(b) expressing the nucleic acids of the host cell of step (a), thereby producing the vitamin K dependent protein in the host cell.
19. The method of claim 18 , wherein the recombinant nucleic acid coding for VKOR is stably expressed.
20. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of:
(a) providing the cell culture system of claim 19 ; and
(b) expressing the recombinant nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.
21. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of
(a) providing the cell culture system of claim 9 , having a recombinant nucleic acid coding for a vitamin K dependent protein integrated into the genome of the cells of the cell culture system; and
(b) expressing the nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.
22. The method of claim 21 , wherein the recombinant nucleic acid coding for a vitamin K dependent protein is stably expressed.
23. A method of producing a vitamin K dependent protein in a cell culture system, comprising the steps of
(a) providing the cell culture system of claim 9 , having a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) integrated into the genome of the cells of the cell culture system; and
(b) expressing the nucleic acids of the cells of the cell culture system of step (a), thereby producing the vitamin K dependent protein in the cell culture system.
24. The method of claim 23 , wherein the recombinant nucleic acid coding for VKOR is stably expressed.